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Approximately 424,000 cases of multidrug-resistant (MDR) tuberculosis (TB) are estimated to have occurred in 2004 (12) . Accordingly, the new Stop TB Strategy and the Global Plan to Stop TB, 2006 -2015 include MDR-TB management as a basic component of TB control (10, 11) . Recognition of a cluster of patients with HIV-associated, extensively drug-resistant TB (XDR-TB) in KwaZulu-Natal Province, South Africa further underscores the need for prompt diagnosis of drug-resistant TB, since mortality was nearly 100% (4) . The WHO Global Task Force on XDR-TB has recommended timely access to drug susceptibility testing for all patients at risk for or suspected to have MDR/XDR-TB (9) .
The microscopic observation drug susceptibility (MODS) assay is a relatively low-cost, simple liquid culture method that relies on microscopic detection of cording growth that is characteristic for M. tuberculosis (1, 3, 6, 7, 8) . Potential advantages of MODS are relatively rapid mycobacterial growth in liquid media and reliance on microscopy skills similar to those used for smear microscopy. MODS has been reported to reliably identify M. tuberculosis isolates with resistance to isoniazid and/or rifampin (3, 6, 7, 8) .
We undertook a prospective study in two settings to further evaluate the performance of MODS for direct detection of M. tuberculosis drug resistance in pulmonary TB suspects at risk for drug resistance.
This study was performed as part of a larger study to evaluate performance of MODS for diagnosis of TB among pulmonary TB suspects at the National Thorax Institute in Honduras, and the Federal University of Rio de Janeiro in Brazil (1). Susceptibility testing was
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performed for all TB suspects prospectively identified as having ≥1 of the following risk factors: a) suspected TB treatment failure, b) suspected TB relapse, c) treatment default, or d) close contact with an MDR-TB case (1). Informed consent was obtained from all subjects, and this study was approved by ethics committees all involved institutions.
Respiratory specimens submitted for routine care purposes were digested and decontaminated using the N-acetyl-L-cysteine-sodium hydroxide (NALC-NaOH) method (5) . Pellets were resuspended in a final volume of 2 ml and used immediately for inoculation of culture media.
Isoniazid stock solution (10,000 ug/ml) was prepared by dissolving 100 mg isoniazid (Sigma) in a final volume of 10 ml sterile distilled water. Rifampin stock solution (10,000 ug/ml) was prepared by dissolving 100 mg rifampin (Sigma) in DMSO, then adding sterile distilled water to a volume of 10 ml. Aliquots were frozen.
MODS liquid medium was prepared as previously described (8) . Antibiotic stock solutions were diluted and added to MODS liquid medium to give the following critical concentrations: INH 0.1 µg/ml ("MODS/INH"), and RIF 2.0 µg/ml ("MODS/RIF"). For each respiratory specimen, 1 ml of drug-free MODS medium was dispensed into one well of a 24-well tissue culture plate (Costar, Corning, NY). One ml of MODS/INH medium was placed into each of 2 adjacent wells, and one ml of MODS/RIF medium was placed into each of 2 additional wells, for a total of 5 wells per respiratory specimen. 0.2 ml aliquots of decontaminated respiratory specimen were inoculated into each of the following: drug-free well, one MODS/INH well, and one MODS/RIF well. In addition, 0.2 ml aliquots of
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by on June 24, 2010 jcm.asm.org Downloaded from decontaminated respiratory specimen diluted 1:10 in MODS medium were inoculated into each of the remaining MODS/INH and MODS/RIF wells. Specimens obtained from different subjects but processed on the same day were plated into different rows of the same plate, and the plate was placed within a gas permeable plastic bag. Plates were incubated at 37°C in 10% CO 2 . The drug-free well was examined twice-weekly for growth and pellicle morphology for 8 weeks, using X40 inverted microscopy. be calculated. In MODS, any growth in drug-containing medium indicates drug resistance, whereas in solid agar testing, growth of less than 1% of that on drug-free medium is interpreted as susceptible. In addition, the bacillary burden in the inocula appeared to have a small effect on drug susceptibility testing, since level of agreement between MODS and the reference standard was slightly higher for 1:10 diluted inocula than for undiluted inocula.
The impact on MODS susceptibility results of the timing of readings and inoculum bacillary burden warrants further study. discordant reference method results. For MODS, critical concentrations were 0.4 µg/ml for isoniazid and 1.0 µg/ml for rifampin. They reported 100% agreement for rifampin (338 isolates tested among which 10.7% were rifampin resistant by the reference method), and 96.7% agreement for isoniazid (334 isolates tested among which 19.5% were resistant) (7) .
Differences between results of various studies may in part be attributable to differences in MODS critical drug concentrations and comparator methods across studies. In addition, in our study, MODS drug-containing wells were examined microscopically on the 14 th day after growth became visible in the corresponding drug free-well, whereas Caviedes and Moore recorded MODS susceptibility results on the same day that growth was observed in the drugfree well (3, 6) . In our study, delayed reading of the MODS wells could have contributed to misclassification of some strains as "resistant".
Taken together, available studies indicate that MODS used as a sole method for drug susceptibility testing could lead, in a small proportion of individuals, to inappropriate designation of isoniazid and/or rifampin resistance. However, the very low likelihood ratio of a negative test indicates that a negative MODS test (i.e. MODS test that is negative for resistance) is useful for "ruling out" resistance. This feature, and the relatively short time between specimen acquisition and susceptibility results, indicate that MODS might be useful as a direct drug susceptibility screening tool in order to prioritize M. tuberculosis isolates for subsequent indirect drug susceptibility testing using conventional methods. There is a need for standardization of MODS methodology for drug susceptibility testing. 

